OCALA, Floride. – New COVID-19 treatment developed in Ocala, Florida is getting measurable results with near-perfect success rate.
The makers of AdventHealth Ocala reported the groundbreaking results of a new drug treatment they developed called ICAM.
“The ICAM protocol has the potential to trigger the reopening of the country,” said Dr. Carlette Norwood-Williams, director of pharmacy at AdventHealth Ocala. “We will know the next step after our outpatient study.”
She said that ICAM works by strengthening the immune system and protecting the lungs from inflammation.
MORE NEWS: How To Make Sure Your Mail-In Ballot Is Counted
“We didn’t need mechanical ventilation and the patients all survived the discharge, regardless of age and medical history,” said Norwood-Williams.
Since April, they have seen a 96.4% survival rate for COVID-19 patients admitted to AdventHealth Ocala.
“It’s a combination of drug classes,” she says. “It works to defend the body against the most severe cases of coronavirus.”
ICAM is an acronym for the types of drugs used: Immunosupport such as vitamin C and zinc; Corticosteroids to control inflammation; Anticoagulants to prevent blood clots; and macrolides to help fight infection.
MORE NEWS: Breonna Taylor’s move sparks protests in US cities, 127 arrests in Louisville
“What we found is that ICAM works as a super defense strategy for the body,” she said. “It doesn’t kill the coronavirus, but it doesn’t have to be. Viruses are self-limiting anyway. They have a very short life cycle. What is killing people are the consequences of the coronavirus in several ways. ”
They are starting a clinical trial for drug therapy in order to publish their results and share the treatment with doctors around the world.
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
Tune in to FOX 35 Orlando for the latest coronavirus news.